Logo image of GL9.I

GLANBIA PLC (GL9.I) Stock Fundamental Analysis

DUB:GL9 - Euronext Dublin - IE0000669501 - Common Stock - Currency: EUR

12.745  +0.27 (+2.21%)

Fundamental Rating

5

Taking everything into account, GL9 scores 5 out of 10 in our fundamental rating. GL9 was compared to 58 industry peers in the Food Products industry. While GL9 has a great profitability rating, there are some minor concerns on its financial health. GL9 has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year GL9 was profitable.
In the past year GL9 had a positive cash flow from operations.
GL9 had positive earnings in each of the past 5 years.
In the past 5 years GL9 always reported a positive cash flow from operatings.
GL9.I Yearly Net Income VS EBIT VS OCF VS FCFGL9.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

GL9's Return On Assets of 4.25% is fine compared to the rest of the industry. GL9 outperforms 62.07% of its industry peers.
GL9 has a Return On Equity of 7.95%. This is comparable to the rest of the industry: GL9 outperforms 53.45% of its industry peers.
GL9 has a Return On Invested Capital of 10.62%. This is amongst the best in the industry. GL9 outperforms 87.93% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GL9 is above the industry average of 6.63%.
The 3 year average ROIC (9.21%) for GL9 is below the current ROIC(10.62%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.25%
ROE 7.95%
ROIC 10.62%
ROA(3y)6.64%
ROA(5y)5.89%
ROE(3y)12.59%
ROE(5y)11.36%
ROIC(3y)9.21%
ROIC(5y)7.85%
GL9.I Yearly ROA, ROE, ROICGL9.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of GL9 (4.29%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of GL9 has declined.
Looking at the Operating Margin, with a value of 10.29%, GL9 is in the better half of the industry, outperforming 62.07% of the companies in the same industry.
In the last couple of years the Operating Margin of GL9 has grown nicely.
Looking at the Gross Margin, with a value of 30.35%, GL9 is doing worse than 67.24% of the companies in the same industry.
GL9's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.29%
PM (TTM) 4.29%
GM 30.35%
OM growth 3Y27.68%
OM growth 5Y13.06%
PM growth 3Y2.53%
PM growth 5Y-1.6%
GM growth 3Y15.03%
GM growth 5Y8.57%
GL9.I Yearly Profit, Operating, Gross MarginsGL9.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GL9 is still creating some value.
The number of shares outstanding for GL9 has been reduced compared to 1 year ago.
GL9 has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, GL9 has a worse debt to assets ratio.
GL9.I Yearly Shares OutstandingGL9.I Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
GL9.I Yearly Total Debt VS Total AssetsGL9.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.39 indicates that GL9 is not in any danger for bankruptcy at the moment.
GL9's Altman-Z score of 3.39 is amongst the best of the industry. GL9 outperforms 82.76% of its industry peers.
The Debt to FCF ratio of GL9 is 2.69, which is a good value as it means it would take GL9, 2.69 years of fcf income to pay off all of its debts.
GL9 has a Debt to FCF ratio of 2.69. This is amongst the best in the industry. GL9 outperforms 87.93% of its industry peers.
A Debt/Equity ratio of 0.45 indicates that GL9 is not too dependend on debt financing.
The Debt to Equity ratio of GL9 (0.45) is better than 62.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.69
Altman-Z 3.39
ROIC/WACC1.62
WACC6.57%
GL9.I Yearly LT Debt VS Equity VS FCFGL9.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.41 indicates that GL9 should not have too much problems paying its short term obligations.
With a Current ratio value of 1.41, GL9 perfoms like the industry average, outperforming 56.90% of the companies in the same industry.
A Quick Ratio of 0.81 indicates that GL9 may have some problems paying its short term obligations.
With a Quick ratio value of 0.81, GL9 perfoms like the industry average, outperforming 43.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 0.81
GL9.I Yearly Current Assets VS Current LiabilitesGL9.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

The earnings per share for GL9 have decreased strongly by -51.61% in the last year.
Measured over the past years, GL9 shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.73% on average per year.
Looking at the last year, GL9 shows a very negative growth in Revenue. The Revenue has decreased by -29.23% in the last year.
Measured over the past years, GL9 shows a decrease in Revenue. The Revenue has been decreasing by -0.19% on average per year.
EPS 1Y (TTM)-51.61%
EPS 3Y-0.29%
EPS 5Y9.73%
EPS Q2Q%-85.84%
Revenue 1Y (TTM)-29.23%
Revenue growth 3Y-6.04%
Revenue growth 5Y-0.19%
Sales Q2Q%-23.73%

3.2 Future

GL9 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.59% yearly.
GL9 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.90% yearly.
EPS Next Y-8.85%
EPS Next 2Y0.33%
EPS Next 3Y3.43%
EPS Next 5Y1.59%
Revenue Next Year1.16%
Revenue Next 2Y2.29%
Revenue Next 3Y2.79%
Revenue Next 5Y10.9%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GL9.I Yearly Revenue VS EstimatesGL9.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
GL9.I Yearly EPS VS EstimatesGL9.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.53, the valuation of GL9 can be described as very reasonable.
74.14% of the companies in the same industry are more expensive than GL9, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.69, GL9 is valued rather cheaply.
GL9 is valuated reasonably with a Price/Forward Earnings ratio of 11.58.
The rest of the industry has a similar Price/Forward Earnings ratio as GL9.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.29, GL9 is valued a bit cheaper.
Industry RankSector Rank
PE 10.53
Fwd PE 11.58
GL9.I Price Earnings VS Forward Price EarningsGL9.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

GL9's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. GL9 is cheaper than 68.97% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, GL9 is valued a bit cheaper than the industry average as 70.69% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.6
EV/EBITDA 7.13
GL9.I Per share dataGL9.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The decent profitability rating of GL9 may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.08
EPS Next 2Y0.33%
EPS Next 3Y3.43%

3

5. Dividend

5.1 Amount

GL9 has a Yearly Dividend Yield of 2.18%.
GL9's Dividend Yield is comparable with the industry average which is at 3.42.
GL9's Dividend Yield is comparable with the S&P500 average which is at 2.43.
Industry RankSector Rank
Dividend Yield 2.18%

5.2 History

The dividend of GL9 is nicely growing with an annual growth rate of 33.32%!
Dividend Growth(5Y)33.32%
Div Incr Years6
Div Non Decr Years6
GL9.I Yearly Dividends per shareGL9.I Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

63.39% of the earnings are spent on dividend by GL9. This is not a sustainable payout ratio.
GL9's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP63.39%
EPS Next 2Y0.33%
EPS Next 3Y3.43%
GL9.I Yearly Income VS Free CF VS DividendGL9.I Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
GL9.I Dividend Payout.GL9.I Dividend Payout, showing the Payout Ratio.GL9.I Dividend Payout.PayoutRetained Earnings

GLANBIA PLC

DUB:GL9 (6/26/2025, 5:27:34 PM)

12.745

+0.27 (+2.21%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-26 2025-02-26/bmo
Earnings (Next)08-12 2025-08-12
Inst Owners22.32%
Inst Owner ChangeN/A
Ins Owners0.68%
Ins Owner ChangeN/A
Market Cap3.25B
Analysts80
Price Target16.48 (29.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.18%
Yearly Dividend0.31
Dividend Growth(5Y)33.32%
DP63.39%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.78%
PT rev (3m)-6.47%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-11.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.3%
Valuation
Industry RankSector Rank
PE 10.53
Fwd PE 11.58
P/S 0.98
P/FCF 10.6
P/OCF 8.51
P/B 1.82
P/tB 8.12
EV/EBITDA 7.13
EPS(TTM)1.21
EY9.49%
EPS(NY)1.1
Fwd EY8.63%
FCF(TTM)1.2
FCFY9.44%
OCF(TTM)1.5
OCFY11.74%
SpS12.97
BVpS7
TBVpS1.57
PEG (NY)N/A
PEG (5Y)1.08
Profitability
Industry RankSector Rank
ROA 4.25%
ROE 7.95%
ROCE 14.01%
ROIC 10.62%
ROICexc 12.26%
ROICexgc 30.25%
OM 10.29%
PM (TTM) 4.29%
GM 30.35%
FCFM 9.27%
ROA(3y)6.64%
ROA(5y)5.89%
ROE(3y)12.59%
ROE(5y)11.36%
ROIC(3y)9.21%
ROIC(5y)7.85%
ROICexc(3y)10.65%
ROICexc(5y)8.91%
ROICexgc(3y)25.6%
ROICexgc(5y)20.78%
ROCE(3y)11.85%
ROCE(5y)10%
ROICexcg growth 3Y28.93%
ROICexcg growth 5Y4.14%
ROICexc growth 3Y21.85%
ROICexc growth 5Y8.02%
OM growth 3Y27.68%
OM growth 5Y13.06%
PM growth 3Y2.53%
PM growth 5Y-1.6%
GM growth 3Y15.03%
GM growth 5Y8.57%
F-Score6
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.69
Debt/EBITDA 1.7
Cap/Depr 55.76%
Cap/Sales 2.27%
Interest Coverage 12.62
Cash Conversion 80.39%
Profit Quality 216.21%
Current Ratio 1.41
Quick Ratio 0.81
Altman-Z 3.39
F-Score6
WACC6.57%
ROIC/WACC1.62
Cap/Depr(3y)51.28%
Cap/Depr(5y)53.27%
Cap/Sales(3y)1.62%
Cap/Sales(5y)1.68%
Profit Quality(3y)136.16%
Profit Quality(5y)132.67%
High Growth Momentum
Growth
EPS 1Y (TTM)-51.61%
EPS 3Y-0.29%
EPS 5Y9.73%
EPS Q2Q%-85.84%
EPS Next Y-8.85%
EPS Next 2Y0.33%
EPS Next 3Y3.43%
EPS Next 5Y1.59%
Revenue 1Y (TTM)-29.23%
Revenue growth 3Y-6.04%
Revenue growth 5Y-0.19%
Sales Q2Q%-23.73%
Revenue Next Year1.16%
Revenue Next 2Y2.29%
Revenue Next 3Y2.79%
Revenue Next 5Y10.9%
EBIT growth 1Y15.59%
EBIT growth 3Y19.97%
EBIT growth 5Y12.85%
EBIT Next Year23.49%
EBIT Next 3Y11.63%
EBIT Next 5Y8.58%
FCF growth 1Y0.56%
FCF growth 3Y21.96%
FCF growth 5Y21.96%
OCF growth 1Y3.48%
OCF growth 3Y16.3%
OCF growth 5Y16.3%